Transscleral diode laser cyclophotocoagulation for refractory glaucoma

Objective To evaluate the effect of transscleral diode laser cyclophotocoagulation on eyes with refractory glaucoma.Methods 32 eyes with refractory glaucoma were received the laser treatments with 1.5～2.0W for 0.5～1 seconds,ranging 180°～360°,12～28 spots.Results The patients were followed six to ten months.IOP were 49.2±9.7 mmHg(33.8～63.7 mmHg) before treatment.IOP were 20.1±6.3 mmHg(12.1～36.2 mmHg) after first time of treatment and 19.6±7.2 mmHg(10.6～33.4 mmHg) at final follow-up.IOP was significantly decreased by transscleral diode laser cyclophotocoagulation(P0.01).The descent rate of IOP of 24 eyes was ≥30%.The success rate of surgery was 75%,and the alleviation rate of pain was 90.6%;The most common complications were anterior chamber reaction and uveitis.Conclusions Transscleral diode laser cyclophotocoagulation is a safe and effective therapy for the management refractory glaucoma,and it can relieve pain without serious complications.